Medtronic plc (MDT)
NYSE: MDT · Real-Time Price · USD
92.71
+1.61 (1.77%)
At close: Aug 22, 2025, 4:00 PM
92.00
-0.71 (-0.77%)
After-hours: Aug 22, 2025, 7:57 PM EDT
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cardiovascular | 12.48B | 12.28B | 12.17B | 11.99B | 11.83B | 12.00B | 11.85B | 11.70B | ||||||||||
| Cardiovascular Growth | 5.49% | 2.27% | 2.71% | 2.50% | 2.35% | 7.00% | 5.85% | 4.01% | ||||||||||
| Neuroscience | 9.85B | 9.77B | 9.67B | 9.51B | 9.41B | 9.27B | 9.17B | 9.06B | ||||||||||
| Neuroscience Growth | 4.67% | 5.38% | 5.49% | 4.88% | 5.00% | 4.79% | 4.81% | 4.24% | ||||||||||
| Medical Surgery | 8.41B | 8.39B | 8.47B | 8.48B | 8.53B | 8.45B | 8.44B | 8.37B | ||||||||||
| Medical Surgery Growth | -1.40% | -0.70% | 0.33% | 1.36% | 2.34% | 0.17% | -1.75% | -5.11% | ||||||||||
| Diabetes | 2.76B | 2.69B | 2.63B | 2.56B | 2.49B | 2.42B | 2.35B | 2.30B | ||||||||||
| Diabetes Growth | 10.73% | 10.90% | 11.90% | 11.22% | 9.99% | 7.02% | 3.29% | -0.35% |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | 17.17B | 16.97B | 16.85B | 16.72B | 16.56B | 16.70B | 16.64B | 16.53B | ||||||||||||||||||||
| United States Growth | 3.67% | 1.62% | 1.27% | 1.14% | 1.15% | 4.38% | 4.83% | 4.63% | ||||||||||||||||||||
| Rest of World | 16.37B | 16.23B | 16.15B | 15.86B | 15.80B | 15.62B | 15.32B | 15.03B | ||||||||||||||||||||
| Rest of World Growth | 3.58% | 3.90% | 5.40% | 5.52% | 6.38% | 5.72% | 2.56% | -1.60% |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative | 10.85B | 10.89B | 10.85B | 10.78B | 10.74B | 10.59B | 10.53B | 10.46B | |||||
| Selling, General, and Administrative Growth | 1.05% | 2.89% | 3.04% | 3.04% | 3.09% | 2.12% | 2.09% | 1.44% | |||||
| Research and Development | 2.73B | 2.72B | 2.74B | 2.74B | 2.74B | 2.70B | 2.69B | 2.67B | |||||
| Research and Development Growth | -0.15% | 0.81% | 1.82% | 2.69% | 1.48% | -0.26% | 0.22% | -0.60% | |||||
| Amortization | 1.81B | 1.66B | 1.67B | 1.68B | 1.69B | 1.70B | 1.71B | 1.70B | |||||
| Amortization Growth | 6.80% | -2.00% | -2.52% | -1.58% | -0.35% | -0.82% | -0.18% | -0.99% | |||||
| Litigation | 361.00M | 212.00M | - | 230.00M | 119.00M | - | 110.00M | 79.00M | 65.00M | - | - | - | - |
| Litigation Growth | 228.18% | 168.35% | - | 253.85% | - | - | - | - | - | - | - | - | - |
| Restructuring | 267.00M | 232.00M | 209.00M | 219.00M | 226.00M | 408.00M | 426.00M | 416.00M | |||||
| Restructuring Growth | 18.14% | -43.14% | -50.94% | -47.36% | -39.89% | 270.91% | 407.14% | 550.00% | |||||
| Other Expenses | -23.00M | 439.00M | 461.00M | 464.00M | 464.00M | 43.00M | -99.00M | -165.00M | |||||
| Other Expenses Growth | - | 920.93% | - | - | - | - | - | - |
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.